•
SB
Scott Barclay
Managing Director, Healthcare at Insight Partners
Palo Alto, California
Overview
Scott Barclay is a Managing Director at Insight Partners, specializing in healthcare investments. With a background in strategy development and product management, he has successfully invested in companies like Swift Medical and Subtle Medical, contributing to their growth and success in the healthcare industry. His expertise in mergers and acquisitions, coupled with his role as a Board Director at Carbon Health and Swift Medical, highlights his impactful contributions to the healthcare startup ecosystem.
Work Experience
Managing Director, Healthcare
2021 - Current
Investing in and serving founders rebuilding healthcare, now as part of the world's best venture capital culture that is Insight Partners. Every stage, every time zone.
Insight Partners is a global software investor that partners with high-growth technology, software, and Internet startup companies.
Founder and GP, Clay VC
2021 - 2022
Clay VC is a new early-stage investing firm rebuilding the future of healthcare by finding and serving founders at the intersection of deep tech, data, and empathy. We call this next era Computational Care. Based in Palo Alto, CA and serving founders globally. (This description is not a solicitation for investment or investment advice)
Partner
2020 - 2021
Building a special purpose diverse team to invest in and serve founders who themselves are technical, ambitious, and building the future of healthcare in the US and globally
Point72 Ventures is an every-stage global VC fund that focuses on fintech, deep tech, and enterprise investments.
Investor
2020 - 2020
Jumped in to help catalyze & fund Fred Turner and a wonderful team to rapidly build a COVID19 Diagnostic oral-liquid diagnostic test
Employer-sponsored health insurance with No Copays, No Deductible. No... Really.
Raised $8,000,000.00 from Refactor, DCVC, Chris Anderson, Undeterred Capital and Justin Mateen.
Board Observer
2019 - 2020
Next-generation blood tests for early cancer detection powered by a machine-driven, multiomics platform. DCVC investor since 2015; Board Observer since July 2019
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Raised $1,351,550,000.00 from BrightEdge Fund, T. Rowe Price, ArrowMark Partners, Roche, Section 32, Sands Capital Ventures, Artis Ventures (AV), Andreessen Horowitz, ARK Investment Management and Pura Vida Investments.
Board Director
2019 - 2020
Building the future of urgent care
Carbon Health is a tech-enabled healthcare company that delivers a virtual care experience.
Raised $622,500,000.00 from BAM Elevate, The K Fund, WP Global Partners, CVS Health Ventures, Nolan Arenado, Sand Hill Angels, Karim Temsamani and Red Hook Capital.
Investor
2018 - 2020
FDA compliance and submission offered as a machine-driven SaaS service
Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
Raised $1,970,000.00 from Brad Flora, Parcel B, Hack VC, Kevin Moore, Soma Capital, Rock Health Capital, Danielle Morrill, Elizabeth Iorns, Refactor and DCVC.
Board Observer
2018 - 2020
"We build machines that read and write"
Primer develops a text analytics solution designed to automate the analysis of textual data.
Raised $237,049,995.00 from Angel Collective Opportunity Fund, Addition and US Innovative Technology Fund.
Board Director
2018 - 2020
Computer vision at the bedside, on the smartphone, solving wound care
Investor
2017 - 2020
Deep leaning to drastically improve imaging infrastructure, in PET and MR
Subtle Medical utilizes AI to enhance various imaging processes, such as PET and MRI scans, improving both speed and quality.
Raised $59,200,000.00 from National Institutes of Health and National Institutes of Health.
Education
Investments
Latest Articles
Behind the Investment: Sensi.AI | Insight Partners
Talks about elderly population growth, aging at home and caregiver burnout
Scaling innovative solutions in women's health with software | Insight Partners
Talks about women's health, femtech and investment in women's health
Investing in Healthtech: Seeding and Scaling Healthcare at the Intersection of Software, Data, and Empathy | Insight Partners
Talks about Insight Partners, healthtech investment and computational care